ADORE BEAUTY GROUP LIMITED (ABY)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ABY - ADORE BEAUTY GROUP LIMITED

Year End: June
GICS Industry Group : No Sector
Index: ALL-ORDS | ALL-TECH

Adore Beauty Group is an Australian online retailer of beauty, skin care and fragrance products. It operates in Australia and New Zealand. It listed on the ASX in 2020.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.80

23 Sep
2021

0.200

OPEN

$4.60

4.35%

HIGH

$4.81

59,684

LOW

$4.58

TARGET
$6.00 25.0% upside
OTHER COMPANIES IN THE SAME SECTOR
AHY . BRG . GFY . GUD . MYR . TRS . SSG . BWX . DSK .
FNARENA'S MARKET CONSENSUS FORECASTS
ABY: 1
Title FY20
Actual
FY21
Actual
FY22
Forecast
FY23
Forecast
EPS (cps) xxx N/A 3.8 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 132.8 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A 0.0% xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 19/05 - 9c

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
Title 2018201920202021
EPS Basic xxxxxxxxx
DPS All xxxxxxxxx0.0
Sales/Revenue xxxxxxxxx179.3 M
Book Value Per Share xxxxxxxxx
Net Operating Cash Flow xxxxxxxxx M
Net Profit Margin xxxxxxxxx %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 2018201920202021
Return on Assets xxxxxxxxx %
Return on Equity xxxxxxxxx %
Return on Total Capital xxxxxxxxx %
Capex xxxxxxxxx M
Capex % of Sales xxxxxxxxx %
Free Cash Flow ex dividends xxxxxxxxx M

Return on Assets

Return on Equity

Return on Total Capital

Capex

Capex % of Sales

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

31/08/2021

1

Buy

$6.00

25.00%

FY21 results were ahead of guidance and demonstrated improved operating momentum.

UBS found it difficult to quantify the benefit from the lockdown, although sales growth of 26% in the current year to date surprised to the upside, particularly as July-August 2020 were the two highest sales months during that year.

The main negative was the outlook for EBITDA margins to be 2-4% in the medium term, as the company reinvests to support top-line growth.

UBS believes the market should be increasingly confident around FY22 forecasts and retains a Buy rating, raising the target to $6.00 from $5.60.

FORECAST
UBS forecasts a full year FY22 dividend of 0.00 cents and EPS of 3.50 cents.
UBS forecasts a full year FY23 EPS of 4.80 cents.

ABY STOCK CHART